Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (18)

2024

  1. Biocompatibility Testing of UV-Curable Polydimethylsiloxane for Human Umbilical Vein Endothelial Cell Culture on-a-Chip

    ACS Omega, Vol. 9, Núm. 28, pp. 30281-30293

  2. Cost–Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study

    Diseases, Vol. 12, Núm. 10

  3. Edoxaban treatment in a post-infarction experimental model

    European Journal of Pharmacology, Vol. 962

2023

  1. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

  2. Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase

    Primary Care Diabetes, Vol. 17, Núm. 4, pp. 366-372

  3. Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  4. NEmecum: digital tool for assisting in the prescription and dispensing of enteral nutrition formulas and infant preparations

    Nutricion Hospitalaria, Vol. 40, Núm. 5, pp. 924-933

  5. Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  6. Vessel-on-a-Chip: A Powerful Tool for Investigating Endothelial COVID-19 Fingerprints

    Cells, Vol. 12, Núm. 9

2022

  1. Impact of Enhanced Phagocytosis of Glycated Erythrocytes on Human Endothelial Cell Functions

    Cells, Vol. 11, Núm. 14

  2. Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252

  3. Management implications associated with switching from vitamin K antagonist anticoagulants to direct oral anticoagulants

    Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 345-347

  4. Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers

    Scientific Reports, Vol. 12, Núm. 1

  5. The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. Biocompatibility analysis of thermal and UV-curable polydimethylsiloxane for semi blood vessel-like model fabrication

    Optics InfoBase Conference Papers

2020

  1. 2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis

    Journal of medicinal chemistry, Vol. 63, Núm. 17, pp. 9237-9257

2017

  1. Non classical Monocytes Levels, Increased by Subcutaneous Fat-Secretome, Are Associated with Less Rehospitalization after Heart Failure Admission

    Journal of Cardiovascular Translational Research, Vol. 10, Núm. 1, pp. 16-26

  2. Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure

    International Journal of Cardiology, Vol. 228, pp. 488-494